Nasdaq Stockholm AB New equity right for trading Oncology Venture TO 1 27819

Nasdaq Stockholm AB: New equity right for trading, Oncology Venture TO 1 (278/19)

03:53 EDT 22 Jul 2019 | FinanzNachrichten

At the request of Oncology Venture A/S, equity rights will be traded on First North as from July 24, 2019. Security name: Oncology Venture TO 1 ------------------------------------- Short name: OV ...

More From BioPortfolio on "Nasdaq Stockholm AB: New equity right for trading, Oncology Venture TO 1 (278/19)"